Relationship between glucagon and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus

Table 3 Covariance analysis of ultrasound attenuation parameter-related factors

	Collinearity statistics
	Tolerance	VIF
Age	0.457	2.191
BMI	0.085	11.734
WC	0.367	2.726
DBP	0.770	1.298
ALT	0.580	1.723
SUA	0.698	1.432
TG	0.785	1.273
HDL	0.787	1.271
INS0 min	0.013	75.684
INS120 min	0.008	131.244
AUCINS 0-180 min	0.005	207.055
HOMA-IR	0.029	34.293
CP0 min	0.126	7.945
CP120 min	0.006	154.348
AUCCP 0-180 min	0.005	185.228
GCG0 min	0.156	6.404
GCGpeak	0.054	18.686
AUCGCG 0-180 min	0.075	13.308
LSM	0.607	1.647
GPR	0.423	2.363
FIB4	0.422	2.368
PBF	0.055	18.162
BMR	0.064	15.617
VFA	0.042	23.946
FFMI	0.060	16.617
FMI	0.024	42.368
SMI	0.029	34.632

Variance inflation factor > 10 or tolerance < 0.1 indicated a strong covariance between the independent variables. UAP: Ultrasound attenuation parameter; VIF: Variance inflation factor; BMI: Body mass index; WC: Waist circumference; DBP: Diastolic blood pressure; ALT: Alanine aminotransferase; SUA: Serum uric acid; TG: Triglycerides; HDL: High-density lipoprotein; GCG: Glucagon; AUC: Area under the curve; INS: Insulin; HOMA-IR: Homeostatic model assessment of insulin resistance; CP: C-peptide; LSM: Liver stiffness measurement; GPR: Gamma glutamyl transpeptidase to platelet ratio; FIB4: Fibrosis 4 score; PBF: Percent body fat; BMR: Basal metabolic rate; VFA: Visceral fat area; FFMI: Fat free mass index; FMI: Fat mass index; SMI: Skeletal muscle index.